SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 35.08 |
| Enterprise Value ($M) | 28.16 |
| Book Value ($M) | 32.59 |
| Book Value / Share | 0.96 |
| Price / Book | 1.08 |
| NCAV ($M) | 10.41 |
| NCAV / Share | 0.31 |
| Price / NCAV | 3.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.01 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.22 |
| Current Ratio | 2.63 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.03 |
| Assets | 59.21 |
| Liabilities | 26.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 101.49 |
| Operating Income | 0.61 |
| Net Income | -0.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 4.20 |
| Cash from Investing | -4.87 |
| Cash from Financing | 7.35 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.99 | -9.28 | |
| 13G/A | Irrevocable Larson Family Investment Trust | 10.70 | 13.49 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 28,437 | 71,776 | 39.62 | |
| 15,242 | 139,450 | 10.93 | |
| 70,644 | 219,841 | 32.13 | |
| 24,937 | 180,696 | 13.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| REVB – Revelation Biosciences, Inc. | RGC – Regencell Bioscience Holdings Limited |
| RGLS – Regulus Therapeutics Inc. | RNAZ – TransCode Therapeutics, Inc. |
| RNTX – Rein Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io